CVB homepage

Trending
Looking ahead to the future of FFR-CT
Medtronic completes $550M acquisition of neurovascular company
FDA clears new computer-assisted device for removing clots in stroke patients
Redo TAVR with balloon-expandable valves linked to positive outcomes, key improvements
Abbott recalls heart device monitoring system due to malfunction risk
Thumbnail
More than 11K bottles of blood pressure drug recalled

Certain lots of a popular diuretic have been recalled due to concerns about the drug's effectiveness. 

Heart cardiologists doctors surgery
Cardiologists and surgeons share early feedback after CMS proposed sweeping TAVR changes

Major TAVR policy changes appear to be on the way—should clinicians be excited or concerned? Leading U.S. medical societies are sharing their early reactions.

The Boston Scientific BodyGuardian Remote Monitoring System uses AI to help detect and monitor cardiac arrhythmias in ambulatory patients.
Cardiology still one of the top specialties for FDA-cleared AI algorithms

Cardiology remains the No. 2 healthcare specialty for AI approvals, trailing only radiology. 

Ziad Ali, MD, DPhil, director of the DeMatteis Cardiovascular Institute, St. Francis Hospital and Heart Center, spoke with Cardiovascular Business about his center's experience using the recently released Johnson & Johnson MedTech next-generation Shockwave C2 Aero Coronary IVL Catheter to treat calcified coronary artery disease. Ali said his center was the first in the world to use the catheter in August 2025 and has since gained experience in roughly 80 cases.
Shockwave Medical's new IVL catheter overcomes previous limitations

Ziad Ali, MD, said the new device has completely changed the way he and his colleagues treat patients with calcified coronary artery disease. 

Medtronic Evolut FX TAVR valve. Medtronic has received an additional CE mark approval for its Evolut Pro+ and FX transcatheter aortic valve replacement (TAVR) valves; they can now be used for redo TAVR in addition to traditional TAVR procedures.
SMART update: Self-expanding TAVR valves still linked to superior durability after 3 years

These three-year data represent a major update to one of the more noteworthy TAVR trials in recent memory.

Video: Vivek Reddy, MD, Director, Cardiac Arrhythmia Service, The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology, Icahn School of Medicine at Mount Sinai, explains studies on the latest pulsed field ablation and leadless conduction pacing trials. #PFA #conductionpacing
Exploring the latest data in PFA and leadless conduction system pacing

Vivek Reddy, MD, spoke to Cardiovascular Business about some of the biggest trends in electrophysiology today.

Boston Scientific’s Seismiq 4CE Coronary IVL Catheter
More good news for Boston Scientific’s coronary IVL tech

Late-breaking data out of EuroPCR focused on 420 patients treated with Boston Scientific's new coronary IVL catheter. Overall, the device was found to be both safe and effective for patients with severe CAD.

How aldosterone works to treat hypertension.
FDA approves first-in-class hypertension drug from AstraZeneca

Baxdrostat, sold by AstraZeneca under the brand name Baxfendy, is now approved to treat hypertension in combination with other antihypertensive medications.

Samuel Jones, MD, MPH, director of inpatient electrophysiology at the Memorial Hospital, Chattanooga Heart Institute, discusses concerns over new heart failure Medicare Ambulatory Specialty Model payment model that starts on Jan. 1, 2027.
Cardiologists scramble to prepare for mandatory heart failure payment model

Samuel Jones, MD, reviews some of the biggest concerns about a new Medicare payment model focused on heart failure care that goes live in 2027. 

Innovation at work

Cardiovascular Business
Fewer biopsies, happier patients: Why molecular blood testing is a game-changer for managing heart transplant recipients

Follow-up care after a successful heart transplant can be challenging—both for providers and their patients. Consider, for example, the fact that so many patients who develop complications never actually present with symptoms.  

In cooperation with CareDx

Around the web

Radiology Business
Boston researchers land $9M grant to advance molecular neuroimaging
Health Exec
OhioHealth agrees to void contracts that allegedly punished payers for including competitors in-network
Health Exec
Nationwide nursing-home picture comes into focus with new analysis